NCT06760234View on ClinicalTrials.gov

Multimodal Deep Learning Model Predicts Pancreatic Cancer Prognosis

Active, not recruitingOBSERVATIONAL
Enrollment

247

Participants

Timeline

Start Date

July 5, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

July 1, 2029

Conditions
Pancreatic Adenocarcinoma
Interventions
DIAGNOSTIC_TEST

No Interventions

The high-throughput extraction of quantitative image features from medical images

DIAGNOSTIC_TEST

No Interventions

Immunohistochemical analysis

Trial Locations (1)

310009

the Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
collaborator

the fourth affiliated hospital, Zhejiang university school of medcine

UNKNOWN

collaborator

Hangzhou Hospital of Traditional Chinese Medicine

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06760234 - Multimodal Deep Learning Model Predicts Pancreatic Cancer Prognosis | Biotech Hunter | Biotech Hunter